HOSPITAL UNIVERSITARIO RUBER
Saila
Instituto de Estudios Catalanes
Barcelona, EspañaInstituto de Estudios Catalanes-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2024
-
Clinicopathological and molecular predictors of [18F]FDG-PET disease detection in HER2-positive early breast cancer: RESPONSE, a substudy of the randomized PHERGain trial
European Journal of Nuclear Medicine and Molecular Imaging